Murine models of cutaneous involvement in lupus erythematosus

Autoimmunity Reviews

Volumn 8, Issue 6, 2009, Pages 484-487

  Ghoreishi, Mehran ^a   Dutz, Jan P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apoptosis; Skin; SLE

Indexed keywords

APOPTOSIS; DENDRITIC CELL; DISEASE EXACERBATION; KERATINOCYTE; LICHENOID ERUPTION; NONHUMAN; REVIEW; SKIN LUPUS ERYTHEMATOSUS; TRANSGENIC MOUSE; ULTRAVIOLET RADIATION;

ANIMALS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KERATINOCYTES; LANGERHANS CELLS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED MRL LPR; MICE, INBRED NOD; MICE, TRANSGENIC; SKIN; SUNLIGHT;

EID: 65549165704     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.02.028     Document Type: Review

References (44)

1. Petri M. Dermatologic lupus: Hopkins Lupus Cohort. Semin Cutan Med Surg 17 (1998) 219-227
2. Pistiner M., Wallace D.J., Nessim S., Metzger A.L., and Klinenberg J.R. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 21 (1991) 55-64
3. Castro J., Balada E., Ordi-Ros J., and Vilardell-Tarres M. The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun Rev 7 (2008) 345-351
4. Hahn B., and Singh R. Animal models of systemic lupus erythematosus. In: Wallace D., and Hahn B. (Eds). Dubois' Lupus Erythematosus (2007), Lippincott Willianms & Wilkins, Philadelphia 299-355 ed^eds
5. Furukawa F. Photosensitivity in cutaneous lupus erythematosus: lessons from mice and men. J Dermatol Sci 33 (2003) 81-89
6. Gilliam J.N., and Sontheimer R.D. Skin manifestations of SLE. Clin Rheum Dis 8 (1982) 207-218
7. Crowson A.N., and Magro C. The cutaneous pathology of lupus erythematosus: a review. J Cutan Pathol 28 (2001) 1-23
8. Sontheimer R.D., and Gilliam J.N. Immunologically mediated epidermal cell injury. Springer Semin Immunopathol 4 (1981) 1-15
9. Weedon D. The lichenoid tissue reaction. Int J Dermatol 21 (1982) 203-206
10. Dutz J.P. T-cell-mediated injury to keratinocytes: insights from animal models of the lichenoid tissue reaction. J Invest Dermatol 129 2 (2009) 309-314
11. Goodnow C.C. Multistep pathogenesis of autoimmune disease. Cell 130 (2007) 25-35
12. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., and Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356 (1992) 314-317
13. Furukawa F., Tanaka H., Sekita K., Nakamura T., Horiguchi Y., and Hamashima Y. Dermatopathological studies on skin lesions of MRL mice. Arch Dermatol Res 276 (1984) 186-194
14. Kanauchi H., Furukawa F., and Imamura S. Characterization of cutaneous infiltrates in MRL/lpr mice monitored from onset to the full development of lupus erythematosus-like skin lesions. J Invest Dermatol 96 (1991) 478-483
15. Horiguchi Y., Furukawa F., Ohshio G., Horio T., and Imamura S. Effects of ultraviolet light irradiation on the skin of MRL/l mice. Arch Dermatol Res 279 (1987) 478-483
16. Peng S.L., Madaio M.P., Hayday A.C., and Craft J. Propagation and regulation of systemic autoimmunity by gammadelta T cells. J Immunol 157 (1996) 5689-5698
17. Peng S.L., McNiff J.M., Madaio M.P., Ma J., Owen M.J., Flavell R.A., et al. Alpha beta T cell regulation and CD40 ligand dependence in murine systemic autoimmunity. J Immunol 158 (1997) 2464-2470
18. Chan O., and Shlomchik M.J. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J Immunol 160 (1998) 51-59
19. Yang J.Q., Saxena V., Xu H., Van Kaer L., Wang C.R., and Singh R.R. Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice. J Immunol 171 (2003) 4439-4446
20. Kinoshita K., Tesch G., Schwarting A., Maron R., Sharpe A.H., and Kelley V.R. Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice. J Immunol 164 (2000) 6046-6056
21. Norman M.U., James W.G., and Hickey M.J. Differential roles of ICAM-1 and VCAM-1 in leukocyte-endothelial cell interactions in skin and brain of MRL/faslpr mice. J Leukoc Biol 84 (2008) 68-76
22. Nishimura H., and Strominger J.L. Involvement of a tissue-specific autoantibody in skin disorders of murine systemic lupus erythematosus and autoinflammatory diseases. Proc Natl Acad Sci U S A 103 (2006) 3292-3297
23. Mehling A., Loser K., Varga G., Metze D., Luger T.A., Schwarz T., et al. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J Exp Med 194 (2001) 615-628
24. Cheng J., Turksen K., Yu Q.C., Schreiber H., Teng M., and Fuchs E. Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice. Genes Dev 6 (1992) 1444-1456
25. Seery J.P., Carroll J.M., Cattell V., and Watt F.M. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis. J Exp Med 186 (1997) 1451-1459
26. Janig E., Pflegerl P., Soleiman A., Meixner A., Petzlbauer P., Wagner E., et al. JunB - a key regulator in autoimmunity. International Investigative Dermatology (2008), Kyoto, Japan Vol. Abstr 147
27. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100 (2003) 2610-2615
28. Graham R.R., Kozyrev S.V., Baechler E.C., Reddy M.V., Plenge R.M., Bauer J.W., et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38 (2006) 550-555
29. Wenzel J., and Tuting T. Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches. Exp Dermatol 16 (2007) 454-463
30. Reefman E., Kuiper H., Limburg P.C., Kallenberg C.G., and Bijl M. Type I interferons are involved in the development of UVB-induced inflammatory skin lesions in Systemic Lupus Erythematosus (SLE) patients. Ann Rheum Dis 67 (2008) 11-18
31. Hida S., Ogasawara K., Sato K., Abe M., Takayanagi H., Yokochi T., et al. CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity 13 (2000) 643-655
32. Wysenbeek A.J., Block D.A., and Fries J.F. Prevalence and expression of photosensitivity in systemic lupus erythematosus. Ann Rheum Dis 48 (1989) 461-463
33. Stern R.S., and Docken W. An exacerbation of SLE after visiting a tanning salon. Jama 255 (1986) 3120
34. Murphy E.D., and Roths J.B. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum 22 (1979) 1188-1194
35. Ansel J.C., Mountz J., Steinberg A.D., DeFabo E., and Green I. Effects of UV radiation on autoimmune strains of mice: increased mortality and accelerated autoimmunity in BXSB male mice. J Invest Dermatol 85 (1985) 181-186
36. Davis P., and Percy J.S. Effect of ultraviolet light on disease characteristics of NZB/W mice. J Rheumatol 5 (1978) 125-128
37. Pickering M.C., Fischer S., Lewis M.R., Walport M.J., Botto M., and Cook H.T. Ultraviolet-radiation-induced keratinocyte apoptosis in C1q-deficient mice. J Invest Dermatol 117 (2001) 52-58
38. Mitchell D.A., Pickering M.C., Warren J., Fossati-Jimack L., Cortes-Hernandez J., Cook H.T., et al. C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J Immunol 168 (2002) 2538-2543
39. Deane J.A., Pisitkun P., Barrett R.S., Feigenbaum L., Town T., Ward J.M., et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27 (2007) 801-810
40. Marshak-Rothstein A., and Rifkin I.R. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol 25 (2007) 419-441
41. Herrmann M., Voll R.E., Zoller O.M., Hagenhofer M., Ponner B.B., and Kalden J.R. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41 (1998) 1241-1250
42. Munoz L.E., Gaipl U.S., Franz S., Sheriff A., Voll R.E., Kalden J.R., et al. SLE-a disease of clearance deficiency?. Rheumatology (Oxford) 44 (2005) 1101-1107
43. O'Brien B.A., Geng X., Orteu C.H., Huang Y., Ghoreishi M., Zhang Y., et al. A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun 26 (2006) 104-115
44. O'Brien B.A., Huang Y., Geng X., Dutz J.P., and Finegood D.T. Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes 51 (2002) 2481-2488